Valvular & structural heart disease

Long-Term Clinical and Echocardiographic Outcomes Following the Ross Procedure: A Post Hoc Analysis of a Randomized Clinical Trial

JAMA CardiolPublished Post hoc analysis of a randomised clinical trial

Authors' conclusion

This study found that the Ross procedure provided excellent survival into the third decade postoperatively that was comparable to that in the general population.

Study context

Population
Adults (age <69 years) with aortic valve disease undergoing the Ross procedure, incl. active endocarditis, rheumatic AVD, decreased EF and previous cardiac surgery98% follow-up completeness
Participants
108 adults
Comparison
Ross procedure vs age-, country of origin- and sex-matched general population
  • Ross proceduren = 108
Primary endpoint
Long-term survival vs matched general population
Follow-up
25 years
Methodological detailssingle-centre, retrospective data collection after 2010, Trial conducted September 1, 1994, to May 31, 2001; median clinical follow-up 24.1 years (IQR, 22.6-26.1 years; 2488 patient-years)
  • Single-centre
  • Retrospective data collection after 2010
  • Trial conducted September 1, 1994, to May 31, 2001; median clinical follow-up 24.1 years (IQR, 22.6-26.1 years; 2488 patient-years)

Primary result

Survival

Relative survival

99.1%

95% CI 91.8%–100%

By group

As reported in the abstract

Secondary outcomes

Freedom from reintervention · 25 years

Freedom from any reintervention
71.1% (95% CI, 61.6%-82.0%)
Freedom from autograft reintervention
80.3% (95% CI, 71.9%-89.6%)
Freedom from homograft reintervention
86.3% (95% CI, 79.0%-94.3%)

Outcomes after Ross-related reintervention

30-day mortality after first Ross-related reintervention
0%
30-day mortality after all Ross-related reinterventions
3.8% (n = 1)
10-year survival after reoperation
96.2% (95% CI, 89.0%-100%)

Original publication

Long-Term Clinical and Echocardiographic Outcomes Following the Ross Procedure: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Cardiol. Published 1 January 2024. doi:10.1001/jamacardio.2023.4090

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.